Q3B(R2)

qualification of impurities in new drug products produced from chemically synthesised new drug substances not previously registered in a region or member state. 1.2 Background This guideline is complementary to the ICH Q3A(R) guideline “Impurities in New Drug Substances”, which should be consulted for basic principles. The ICH Q3C ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download